Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • MCA
    Junior Member
    • Jul 2014
    • 1

    #1

    Optimizing on NextSeq

    Howdy,

    I work for a clinical genomics company, we have a NextSeq 500 and have been trying to squeeze the most reads per sample out of it.

    What I've been running:
    Multiplexed 24 Human DNA samples
    TruSight One enrichment panel, 8bp barcodes, paired end
    NextSeq MidOutput Flowcell, run as 2x 150 cycle

    We've been consistently been getting:
    60Gb data
    180million sequences
    ~70-80% Passing filter
    ~70-80% Q30
    Samples have average 80x coverage of the panel

    I've been able to get that high by loading a much higher pM concentration on the flowcell, and finding out at which concentration it begins to overcluster and filter out data.

    I'd like to know, is this normal? I assume other labs are trying to maxmize data, dose anyone have similar (or better) results? Illumina seemed tight lipped about our results, neither condemning or condoning us overclustering. We are planning on switching to a HiSeq 3000, would we be able to go beyond (at our own risk) the recommended specs?

    I heard that the HiSeq has patterned flowcells, would this set a ceiling to prevent clustering too high?

    Also, if you have any NextSeq questions feel free to ask!

    -Plunk
  • ScottC
    Senior Member
    • Jan 2008
    • 244

    #2
    In our experience, the NextSeq is by far the most tolerant of the Illumina systems in terms of pushing the cluster numbers (second after that is the old GA/II/IIx), although the patterned flowcells of the 3000 might change that. We get similar figures to those you posted on our NextSeq.
    Last edited by ScottC; 04-05-2016, 04:07 PM.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    40 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    41 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    45 views
    0 reactions
    Last Post SEQadmin2  
    Working...